Valar Labs, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Valar Labs, Inc. - overview
Established
2021
Location
Palo Alto, CA, US
Primary Industry
Healthcare IT
About
Established in 2021 and based in California, US, Valar Labs, Inc. operates as a provider of an (artificial intelligence) AI-based platform that primarily helps oncologists by answering clinical questions related to the patient’s characteristics. In May 2024, Valar Labs, Inc. raised USD 22 million in series A funding co-led by new investor Data Collective and returning investor Andreessen Horowitz, with participation from another returning investor Pear VC.
Valar Labs provides an AI-powered platform to assist oncologists in reimagining treatment decisions treatment for cancer patients. The company’s client base includes academic medical centers and community oncologists. The company plans to use its proceeds from May 2024 funding to support its expansion and the development of its product called Vesta.
Current Investors
Andreessen Horowitz, Pear VC, DCVC
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Oncology/Cancer Treatment, Medical Software
Website
www.valarlabs.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.